ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.

Journal of molecular histology

Volumn 44, Issue 5, 2013, Pages 555-563

  Zhou, Yehui ^a   Lan, Jing ^b   Wang, Wei ^b   Shi, Qin ^b   Lan, Yang ^b   Cheng, Zhiyi ^b   Guan, Honggeng ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; KI 67 ANTIGEN; TCF4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; ZINC AND RING FINGER 3 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; APOPTOSIS; CANCER GRADING; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; ADULT; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; WNT SIGNALING PATHWAY;

EID: 84899044321     PISSN: None     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9504-9     Document Type: Article

References (32)

1. X Chen SY Leung ST Yuen KM Chu J Ji R Li AS Chan S Law OG Troyanskaya J Wong 2003 Variation in gene expression patterns in human gastric cancers Mol Biol Cell 14 3208 3215 12925757 10.1091/mbc.E02-12-0833 1:CAS:528:DC%2BD3sXmvFWksr0%3D Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J et al (2003) Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14:3208–3215
2. LY Cho JJ Yang KP Ko SH Ma A Shin BY Choi DS Han KS Song YS Kim SH Chang 2012 Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk PLoS ONE 7 e47603 23110082 10.1371/journal.pone.0047603 1:CAS:528:DC%2BC38Xhs1GjtLnE Cho LY, Yang JJ, Ko KP, Ma SH, Shin A, Choi BY, Han DS, Song KS, Kim YS, Chang SH et al (2012) Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk. PLoS ONE 7:e47603
3. H Clevers 2006 Wnt/beta-catenin signaling in development and disease Cell 127 469 480 17081971 10.1016/j.cell.2006.10.018 1:CAS:528:DC%2BD28Xht1WhtbbN Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480
4. H Clevers R Nusse 2012 Wnt/beta-catenin signaling and disease Cell 149 1192 1205 22682243 10.1016/j.cell.2012.05.012 1:CAS:528:DC%2BC38XosVaktrg%3D Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149:1192–1205
5. JL Freese D Pino SJ Pleasure 2010 Wnt signaling in development and disease Neurobiol Dis 38 148 153 19765659 10.1016/j.nbd.2009.09.003 1:CAS:528:DC%2BC3cXksFCmsbY%3D Freese JL, Pino D, Pleasure SJ (2010) Wnt signaling in development and disease. Neurobiol Dis 38:148–153
6. S Gencer G Sen G Dogusoy AK Belli M Paksoy MB Yazicioglu 2010 beta-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers Turk J Gastroenterol 21 224 230 20931424 Gencer S, Sen G, Dogusoy G, Belli AK, Paksoy M, Yazicioglu MB (2010) beta-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers. Turk J Gastroenterol 21:224–230
7. TN Grossmann JT Yeh BR Bowman Q Chu RE Moellering GL Verdine 2012 Inhibition of oncogenic Wnt signaling through direct targeting of beta-catenin Proc Natl Acad Sci USA 109 17942 17947 23071338 10.1073/pnas.1208396109 1:CAS:528:DC%2BC38Xhsl2ktbvI Grossmann TN, Yeh JT, Bowman BR, Chu Q, Moellering RE, Verdine GL (2012) Inhibition of oncogenic Wnt signaling through direct targeting of beta-catenin. Proc Natl Acad Sci USA 109:17942–17947
8. HX Hao Y Xie Y Zhang O Charlat E Oster M Avello H Lei C Mickanin D Liu H Ruffner 2012 ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner Nature 485 195 200 22575959 10.1038/nature11019 1:CAS:528:DC%2BC38XmvVeqsLg%3D Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195–200
9. Heo SH, Jeong ES, Lee KS, Seo JH, Jeong DG, Won YS, Kwon HJ, Kim HC, Kim DY, Choi YK (2012) Canonical Wnt signaling pathway plays an essential role in N-methyl-N-nitrosurea induced gastric tumorigenesis of mice. J Vet Med Sci [Epub ahead of print]
10. MS Kim SS Kim CH Ahn NJ Yoo SH Lee 2009 Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability Hum Pathol 40 58 64 18755497 10.1016/j.humpath.2008.06.006 1:CAS:528:DC%2BD1cXhsVWrsLbK Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH (2009) Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol 40:58–64
11. FT Kolligs G Bommer B Goke 2002 Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis Digestion 66 131 144 12481159 10.1159/000066755 1:CAS:528:DC%2BD38XpsV2htLs%3D Kolligs FT, Bommer G, Goke B (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66:131–144
12. AM Lowy WM Clements J Bishop L Kong T Bonney K Sisco B Aronow C Fenoglio-Preiser J Groden 2006 beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer Cancer Res 66 4734 4741 16651426 10.1158/0008-5472.CAN-05-4268 1:CAS:528:DC%2BD28XjvF2ktrw%3D Lowy AM, Clements WM, Bishop J, Kong L, Bonney T, Sisco K, Aronow B, Fenoglio-Preiser C, Groden J (2006) beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 66:4734–4741
13. J Ma R Wang X Fang Z Sun 2012 beta-Catenin/TCF-1 Pathway in T Cell Development and Differentiation J Neuroimmune Pharmacol 7 750 762 22535304 10.1007/s11481-012-9367-y Ma J, Wang R, Fang X, Sun Z (2012) beta-Catenin/TCF-1 Pathway in T Cell Development and Differentiation. J Neuroimmune Pharmacol 7:750–762
14. BT MacDonald X He 2012 A finger on the pulse of Wnt receptor signaling Cell Res 22 1410 1412 22688894 10.1038/cr.2012.91 1:CAS:528:DC%2BC38XhsVequ73N MacDonald BT, He X (2012) A finger on the pulse of Wnt receptor signaling. Cell Res 22:1410–1412
15. GJ Offerhaus FM Giardiello AJ Krush SV Booker AC Tersmette NC Kelley SR Hamilton 1992 The risk of upper gastrointestinal cancer in familial adenomatous polyposis Gastroenterology 102 1980 1982 1316858 1:STN:280:DyaK383mslaquw%3D%3D Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, Hamilton SR (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982
16. N Ogasawara T Tsukamoto T Mizoshita K Inada X Cao Y Takenaka T Joh M Tatematsu 2006 Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer Histopathology 49 612 621 17163846 10.1111/j.1365-2559.2006.02560.x 1:STN:280:DC%2BD28jis1Wltg%3D%3D Ogasawara N, Tsukamoto T, Mizoshita T, Inada K, Cao X, Takenaka Y, Joh T, Tatematsu M (2006) Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49:612–621
17. K Okuno F Sugiura J Hida T Tokoro E Ishimaru K Ueda 2011 Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer Gan To Kagaku Ryoho 38 1906 1908 22202234 Okuno K, Sugiura F, Hida J, Tokoro T, Ishimaru E, Ueda K (2011) Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer. Gan To Kagaku Ryoho 38:1906–1908
18. DM Parkin 2004 International variation Oncogene 23 6329 6340 15322508 10.1038/sj.onc.1207726 1:CAS:528:DC%2BD2cXmvVOrtLY%3D Parkin DM (2004) International variation. Oncogene 23:6329–6340
19. N Pecina-Slaus 2010 Wnt signal transduction pathway and apoptosis: a review Cancer Cell Int 10 22 20591184 10.1186/1475-2867-10-22 Pecina-Slaus N (2010) Wnt signal transduction pathway and apoptosis: a review. Cancer Cell Int 10:22
20. W Remmele HE Stegner 1987 Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138 140 3303008 1:STN:280:DyaL2s3ovFGhsQ%3D%3D Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140
21. A Schepers H Clevers 2012 Wnt signaling, stem cells, and cancer of the gastrointestinal tract Cold Spring Harb Perspect Biol 4 a007989 22474007 10.1101/cshperspect.a007989 Schepers A, Clevers H (2012) Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol 4:a007989
22. MG Smith GL Hold E Tahara EM El-Omar 2006 Cellular and molecular aspects of gastric cancer World J Gastroenterol 12 2979 2990 16718776 1:CAS:528:DC%2BD28XmtVOnur4%3D Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979–2990
23. Y Sun 2003 Targeting E3 ubiquitin ligases for cancer therapy Cancer Biol Ther 2 623 629 14688465 1:CAS:528:DC%2BD2cXhvVCjsLw%3D Sun Y (2003) Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther 2:623–629
24. Y Sun 2006 E3 ubiquitin ligases as cancer targets and biomarkers Neoplasia 8 645 654 16925947 10.1593/neo.06376 1:CAS:528:DC%2BD28XhtVGltbjE Sun Y (2006) E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8:645–654
25. L Topol X Jiang H Choi L Garrett-Beal PJ Carolan Y Yang 2003 Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation J Cell Biol 162 899 908 12952940 10.1083/jcb.200303158 1:CAS:528:DC%2BD3sXntFeqsbw%3D Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899–908
26. Turing AM (1990) The chemical basis of morphogenesis. 1953. Bull Math Biol 52:153–197; discussion 119–152
27. T Ushijima M Sasako 2004 Focus on gastric cancer Cancer Cell 5 121 125 14998488 10.1016/S1535-6108(04)00033-9 1:CAS:528:DC%2BD2cXhvVOntLc%3D Ushijima T, Sasako M (2004) Focus on gastric cancer. Cancer Cell 5:121–125
28. TJ Wieman SW Taber DN Reed Jr GC Vitale 2003 Upper gastrointestinal cancer risk in familial adenomatous polyposis J Ky Med Assoc 101 142 145 12710248 Wieman TJ, Taber SW, Reed DN Jr, Vitale GC (2003) Upper gastrointestinal cancer risk in familial adenomatous polyposis. J Ky Med Assoc 101:142–145
29. L Wolpert 1969 Positional information and the spatial pattern of cellular differentiation J Theor Biol 25 1 47 4390734 10.1016/S0022-5193(69)80016-0 1:STN:280:DyaE3c%2FivFWrtg%3D%3D Wolpert L (1969) Positional information and the spatial pattern of cellular differentiation. J Theor Biol 25:1–47
30. J Wu Y Jiao M Dal Molin A Maitra RF Wilde de LD Wood JR Eshleman MG Goggins CL Wolfgang MI Canto 2011 Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways Proc Natl Acad Sci USA 108 21188 21193 22158988 10.1073/pnas.1118046108 1:CAS:528:DC%2BC38XnvVGhuw%3D%3D Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI et al (2011) Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA 108:21188–21193
31. R Yagyu Y Furukawa YM Lin T Shimokawa T Yamamura Y Nakamura 2004 A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer Int J Oncol 25 1343 1348 15492824 1:CAS:528:DC%2BD2cXhtVSktbjF Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T, Nakamura Y (2004) A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int J Oncol 25:1343–1348
32. K Yoshimatsu H Yokomizo G Osawa T Fujimoto T Otani T Tsunoda Y Nakamura K Ogawa 2008 Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer Gan To Kagaku Ryoho 35 2268 2270 19106592 Yoshimatsu K, Yokomizo H, Osawa G, Fujimoto T, Otani T, Tsunoda T, Nakamura Y, Ogawa K (2008) Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer. Gan To Kagaku Ryoho 35:2268–2270